Reshma Rangwala
Evp & Chief Medical Officer at Karyopharm Therapeutics Inc. (KPTI)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $56K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 15SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 40856,829 held (−1%) | $9.50 | $4K | -95.9% |
| Apr 22SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 44956,290 held (−1%) | $8.94 | $4K | -95.6% |
| Mar 3SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 5,06656,739 held (−8%) | $9.41 | $48K | -95.9% |